|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 106.92 USD | +0.39% |
|
+2.74% | +34.83% |
| 01:28pm | CVS Health Opens Pharmacy-Focused Location in Houston | MT |
| 12:50pm | Cvs Health Unveils First Pharmacy-Focused Cvs Pharmacy Location in Houston | CI |
| Market Cap | 136B 119B 110B 101B 190B 13,086B 195B 1,310B 515B 6,409B 510B 499B 22,063B | P/E 2026 * |
17x | P/E 2027 * | 14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 192B 168B 155B 142B 269B 18,461B 275B 1,848B 727B 9,041B 720B 704B 31,124B | EV / Sales 2026 * |
0.47x | EV / Sales 2027 * | 0.44x |
| Free-Float |
71.2% | Yield 2026 * |
2.5% | Yield 2027 * | 2.57% |
Last Transcript: CVS Health Corporation
| 1 day | +0.37% | ||
| 1 week | +2.74% | ||
| Current month | +3.43% | ||
| 1 month | +7.91% | ||
| 3 months | +38.42% | ||
| 6 months | +33.60% | ||
| Current year | +34.83% |
| 1 week | 103.56 |  | 108.97 |
| 1 month | 97.84 | | 108.97 |
| Current year | 69.51 | | 108.97 |
| 1 year | 58.5 | | 108.97 |
| 3 years | 43.56 | | 108.97 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
Ali Keshavarz
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/26/26 | Tax | Controller/Auditor | -454 | 0.0000% | ||
| 5/31/26 | Tax | Chief Financial Officer | -2,478 | 0.0002% | ||
| 5/31/26 | Tax | Chief Technology Officer | -7,618 | 0.0006% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.39% | +2.74% | +69.04% | +50.34% | 136B | |
| -3.10% | -8.01% | +3.15% | +28.15% | 85.57B | |
| -0.24% | -1.97% | +1.16% | +59.76% | 26.95B | |
| +0.59% | +1.35% | +25.01% | +50.27% | 23.18B | |
| +1.27% | +0.75% | -16.17% | -28.01% | 20.05B | |
| -1.51% | -3.89% | +12.09% | +143.41% | 17.16B | |
| -0.50% | -0.86% | +6.34% | +8.87% | 15.47B | |
| +0.59% | +1.18% | +64.28% | +125.33% | 15.02B | |
| +0.45% | +0.74% | -9.34% | -11.28% | 12.78B | |
| -0.81% | -1.02% | -13.87% | +81.50% | 11.1B | |
| Average | -0.36% | -0.10% | +14.17% | +50.83% | 36.32B | |
| Weighted average by Cap. | -0.61% | +0.02% | +30.11% | +46.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 409B 358B 330B 304B 574B 39,427B 586B 3,946B 1,552B 19,310B 1,538B 1,504B 66,473B | 427B 373B 344B 317B 598B 41,092B 611B 4,113B 1,618B 20,125B 1,602B 1,567B 69,280B |
| Net income | 8.04B 7.03B 6.49B 5.98B 11.27B 775B 11.52B 77.54B 30.5B 379B 30.21B 29.55B 1,306B | 9.35B 8.17B 7.54B 6.95B 13.09B 900B 13.38B 90.08B 35.43B 441B 35.1B 34.33B 1,517B |
| Net Debt | 55.81B 48.77B 45.01B 41.48B 78.19B 5,375B 79.93B 538B 212B 2,632B 210B 205B 9,062B | 52.23B 45.64B 42.12B 38.82B 73.17B 5,030B 74.8B 503B 198B 2,463B 196B 192B 8,480B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | US$106.95 | +0.42% | 3,339,699 |
| 26-07-16 | US$106.50 | +0.56% | 12,025,143 |
| 26-07-15 | US$105.91 | -0.25% | 6,939,634 |
| 26-07-14 | US$106.18 | +0.26% | 11,396,143 |
| 26-07-13 | US$105.90 | +1.68% | 7,264,352 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
